Begleiten Sie Dr. Mark Ebell und Dr. Michael Wilkes, während sie wöchentlich wichtige medizinische Studien analysieren und in fünf Minuten wertvolle Einblicke für die Praxis bieten.
Episode 695: Monoclonal antibodies for Alzheimer disease: A lack of clinically meaningful benefits, plus significant harms
11 mins • Apr 1, 2024
Charts
This show is not currently ranked in any charts.
Neueste Folgen
Apr 1, 2024
Episode 695: Monoclonal antibodies for Alzheimer disease: A lack of clinically meaningful benefits, plus significant harms
11 mins
Mar 25, 2024
Episode 694: Patient reminders combined with clinician audit and feedback increases human papillomavirus vaccine uptake
6 mins
Mar 18, 2024
Episode 693: Canadian Thoracic Society guidelines for pharmacotherapy of stable chronic obstructive pulmonary disease
7 mins
Mar 11, 2024
Episode 692: Scottish screening: 0 cases of invasive cervical cancer in women who received at least 1 dose of bivalent HPV vaccine at 12 or 13 years of age
7 mins
Mar 4, 2024
Episode 691: High-dose recombinant flu vaccine: NNT = 3000 to prevent one more infection, no impact on hospitalization
6 mins
Sprache
Englisch
Land
Vereinigte Staaten
Kategorien
Website
Feed
Aktualisierung anfordern
Aktualisierungen können einige Minuten dauern.